Regencell Bioscience Holdings LtdNASDAQ:RGC
- LAST PRICE5.6500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots5.4300/ 2
- Ask / Lots6.6500/ 3
- Open / Previous Close--- / 5.6500
- Day Range---
- 52 Week Range
- Volume2
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGC |
|---|---|---|
| 09:42 ET | 400 | 5.89 |
| 10:06 ET | 300 | 5.71 |
| 10:24 ET | 4516 | 5.8499 |
| 10:38 ET | 100 | 5.93 |
| 10:56 ET | 200 | 5.7011 |
| 11:14 ET | 1000 | 5.8 |
| 11:16 ET | 5100 | 5.789 |
| 12:12 ET | 180 | 5.8 |
| 12:57 ET | 100 | 6.0828 |
| 01:51 ET | 100 | 5.9832 |
| 02:16 ET | 258 | 5.9843 |
| 02:45 ET | 200 | 5.85 |
| 03:01 ET | 200 | 5.81 |
| 03:21 ET | 400 | 5.85 |
| 03:37 ET | 138 | 5.85 |
| 03:46 ET | 100 | 5.855 |
| 03:51 ET | 2448 | 5.93 |
| 03:55 ET | 2997 | 5.9101 |
| 03:57 ET | 400 | 5.83 |
| 04:00 ET | 917 | 5.65 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regencell Bioscience Holdings Ltd | 73.5M | -17.1x | --- |
Adicet Bio Inc | 75.3M | -0.5x | --- |
Aerovate Therapeutics Inc | 75.3M | -0.9x | --- |
Ovid Therapeutics Inc | 75.2M | -2.3x | --- |
Citius Oncology Inc | 69.6M | 4.0x | --- |
ESSA Pharma Inc | 78.1M | -2.8x | --- |
Company Information
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Contact Information
- Headquarters
- 11/F First Commercial Building 33-35 Leighton Roa, Hong Kong 999077
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $73.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 13.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.67 |
EPS | $-0.33 |
Book Value | $0.63 |
P/E Ratio | -17.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
